Objective: Delayed neck metastasis is the most significant prognostic factor for early tongue cancer. The main strategies for controlling cervical lymph nodes in Japan are elective neck dissection or watchful waiting. Elective neck dissection offers significantly better survival, but adversely impacts patient quality of life; consequently, here we investigated how to identify high-risk patients warranting elective neck dissection. Methods: We retrospectively evaluated 67 patients with T1N0 oral tongue squamous cell carcinoma who underwent primary treatment in our department from April 2001 to March 2015. All the patients underwent watchful waiting alone for neck management. We investigated the rates of occult neck metastasis, prognosis and circumstances of recurrence, and associations with pathological tumor thickness, depth and muscle invasion by the primary tumor. Correlation between the thickness in pathological specimens and that at magnetic resonance imaging was additionally investigated. Results: Neck recurrence was evident in 20 patients, of which 19 developed within 1 year. Therefore, the rate of occult neck metastasis was 29.9%. Patients with muscle invasion, tumor thickness ≥2 mm or tumor depth ≥2 mm on surgical specimens were significantly more likely to develop delayed neck metastasis. Prognosis was significantly worse for patients with muscle invasion or tumor thickness ≥2 mm. Thickness using magnetic resonance imaging was well correlated with pathological thickness. Conclusions: Patients with tumors ≥2 mm in thickness or muscle invasion developed neck metastasis, suggesting that elective neck dissection may be warranted for patients with these findings. For preoperative assessment of the need for elective neck dissection, magnetic resonance imaging would be a potential modality for T1N0 tongue cancer.
Introduction
In head and neck cancer, the diagnosis of N0 is currently made not only by palpation, but also using a wide range of imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US) and positron-emission tomography (PET)-CT. However, undetectable occult neck metastasis is present in a certain proportion of patients. Rates of occult neck metastasis vary depending on the location of the primary tumor, with a reported rate of 23-36% for T1N0 oral tongue cancer cases (1) (2) (3) . Patients with occult neck metastasis who undergo transoral primary resection alone develop clinically apparent delayed neck metastasis in the early period within 18 months postoperatively (4) . Even patients with early-stage oral tongue cancer show a poor prognosis if delayed neck metastasis develops, and control of cervical lymph nodes is important. However, the optimal methodology for cervical lymph-node control remains unclear.
Three main strategies are currently used for the control of cervical lymph nodes: elective neck dissection (END) (5, 6) , watchful waiting (WW) (7, 8) and sentinel lymph-node biopsy (9, 10) . In Japan, however, sentinel lymph-node biopsy for head and neck cancer is not currently covered by health care insurance. A recent largescale single center Phase III randomized comparative clinical trial divided patients with early-stage oral cancer including T1N0 tongue cancer into those who underwent END and those who only underwent transoral primary resection followed by WW; neck dissection was performed as salvage surgery in the event of delayed neck recurrence after follow-up. Survival was significantly better for the END group than for the WW group (5) . This was an important study demonstrating the superiority of END over WW for patients with early-stage oral cancer, including tongue cancer. Neck dissection does, however, leave a large surgical scar on the skin of the neck, and causes postoperative stiffness and/or constriction of the shoulders and neck, as well as impaired shoulder elevation (11) . In addition, there is a risk of marginal mandibular nerve injury (12, 13) and other potential damage. We, therefore, consider the question of how to focus END on high-risk patients who require this procedure, rather than performing it in all patients, as an important issue.
Our department uses imaging modalities including CT, MRI or PET-CT to reach a definitive diagnosis of clinical N0. Until 2015, all patients with T1N0 tongue cancer underwent primary resection comprising transoral partial glossectomy alone, followed by careful WW of the cervical lymph nodes, with therapeutic neck dissection performed only in the event of neck recurrence. We undertook a retrospective study of 67 patients with T1N0 oral tongue squamous cell carcinoma (SCC) who underwent primary treatment in our department during the past 15 years. The rate of occult neck metastasis, the prognosis for patients with delayed neck recurrence and the circumstances of recurrence were ascertained. We also investigated the association between delayed neck recurrence and pathological thickness, depth and muscle invasion of the primary tumor. Finally, we examined the correlations between tumor thickness on magnetic resonance (MR) images and tumor thickness in pathological specimens. The aim of this study was to identify patients at high risk of having occult neck metastasis who should therefore undergo END.
Patients and methods
The Institutional Review Board of Miyagi Cancer Center approved the study protocol, which was conducted in accordance with the Helsinki Declaration. This was a retrospective clinical observational study. Primary treatment was performed for 272 patients with SCC of the tongue in our department during the 15-year period from April 2001 to March 2015. Of these, 67 (24.6%) patients with oral tongue SCC were classified as T1N0. The diagnosis of N0 was based on imaging findings from CT and/or MRI and/or PET-CT in all cases. All 67 patients underwent transoral partial glossectomy alone as primary treatment, and no patient underwent END. In all cases, pathological findings showed negative surgical margins, and no patients received adjuvant treatment.
As to the terminology of lymph-node metastasis, 'delayed neck metastasis' is defined as clinically overt metastasis that developed from 'occult neck metastasis' that had been present at the initial treatment and had escaped detection during careful examinations.
Data collection
We investigated the following factors: sex, age, smoking history, habitual drinking of alcohol, the presence of multiple primary cancers, follow-up period, overall survival (OS) rate, disease-specific survival (DSS) rate and relapse-free survival (RFS) rate. For patients who developed recurrence, we also investigated the recurrence pattern, timing and outcome.
We then investigated correlations between pathological muscle invasion, tumor thickness, tumor depth, delayed neck recurrence and prognosis. Two of the sixty-seven patients had undergone excisional biopsy at another hospital, significantly reducing the tumor volume, and as this made tumor thickness and depth difficult to investigate; consequently, these patients were excluded from the pathological analysis. Maximum tumor thickness and maximum tumor depth were all measured from tumor sections and recorded. Maximum tumor thickness was measured vertically from the tumor surface to its deepest extent in pathological specimens. In ulcerative tumor, the virtual tumor surface was reconstructed in the ulcer floor, and then the thickness was defined as the distance from the ulcer floor to the vertical end of the tumor extension (14) . Maximum tumor depth was measured as the invasion depth, with the origin on a line from the tumor to the adjacent mucosal layer (Fig. 1) , regardless of the presence or absence of ulceration (14) . All slides were evaluated by I.S., a board-certified pathologist, who was blinded to the clinical information of each patient.
We additionally examined tumor thickness on preoperative MR images and investigated the correlation between tumor thickness on those images and on surgical specimens. Tumor thickness at MRI was measured using fat-suppression contrast-enhanced T1-weighted images vertically from the tumor surface to its deepest portion of invasion (Fig. 2a) . Slice thicknesses were within the range from 3 to 5 mm. MR images were evaluated by K.M., a diagnostic radiologist who specializes in head and neck cancers. All of the images were evaluated without any information concerning the corresponding pathological findings. Of the 65 cases involving pathological analysis, 6 did not undergo MRI in the preoperative period and 5 could not be evaluated because of the artifacts caused by dental metals or magnetic attachment. Additionally, in 9 cases, MR images were lost during the 15-year period. Therefore, the remaining 45 cases constituted MRI measurement study.
Statistical analysis
For statistical analysis, the Kaplan-Meier method was used to investigate survival, and log-rank testing was used to test for statistically significant differences in survival. A χ 2 test was used for comparisons between two independent groups, with Yates' correction used if there were one or more parameters <5, or 2 or more between 5 and 10. A t-test was used to compare mean values between the groups. Pearson's correlation coefficient was employed to examine the correlation between the two groups. For all tests, values of P < 0.05 were regarded as significant.
Follow-up method
Because this was a retrospective study, follow-up policy could not be rigorously specified; however, at our department we routinely performed CT, MRI and/or PET-CT at 1, 3, 6, 12, 18, 24, 36, 48 and 60 months postoperatively. Visual inspection and palpation was carried out postoperatively once a month during the first year, every 2 months during the second year, every 3 months during the third year, every 4 months during the fourth year and every 6 months during the fifth year and thereafter. The above-mentioned imaging tests or US, including fine needle aspiration cytology, was additionally performed at the time of suspicion of recurrence.
Results

Patient characteristics
Because pathological analysis revealed negative surgical margins in all 67 patients, no additional treatment was required and none was administered in any case. 
months).
Nine of the sixty-seven patients died of the primary cancer, and five from other causes. Four of these five patients died of multiple primary cancers, and one of heart disease. The OS rate was 85.7% at 3 years and 79.4% at 5 years (Fig. 3a) . The DSS rate was 89.2% at 3 years and 87.3% at 5 years (Fig. 3b) . 
Neck recurrence and prognosis
For tongue cancer recurrence alone, excluding other causes of death, the RFS rates were 70.6% at 1 year, 70.6% at 2 years, 66.9% at 3 years and 61.2% at 5 years (Fig. 3c) . Recurrence was evident in 26 patients (38.8%), comprising ipsilateral neck recurrence in 20, recurrence at the primary site in 5, and simultaneous recurrence at the primary site and cervical lymph-node metastasis in 1. In this study, cervical lymph-node recurrence by itself was defined as delayed neck lymph-node metastasis recurrence, and the occult neck metastasis rate was 29.9%. Ipsilateral neck recurrence developed within 1 year postoperatively in 19 of the 20 patients, and the median time to recurrence was 6.4 months. In contrast, recurrence at the primary site occurred late, at between 31.3 and 117.8 months postoperatively, with a median time to recurrence of 55.6 months.
Therapeutic neck dissection was performed as salvage surgery in 19 of the 20 patients who developed neck recurrence. In the remaining patient, the tumor was resectable; however, because the patient was very old and also suffered from dementia, surgery was rejected in favor of best supportive care. Of the 19 patients who underwent therapeutic neck dissection after recurrence, 13 (68.4%) had at least stage pN2b metastasis; extracapsular spread (ECS) was present in 16 (84.2%), meaning that patients with neck recurrence were already at an advanced stage of disease at the time of recurrence. Eight of the nineteen patients underwent postoperative radiotherapy or postoperative concurrent chemoradiotherapy with cisplatin. Nine (45%) of the twenty patients with neck recurrence developed further uncontrollable recurrence and died of the primary cancer (Table 1) . No differences were seen between patients who were positive and negative for occult neck metastasis in terms of factors such as sex, age, smoking, drinking and the presence of double cancers (Table 1) .
Pathological factors and occult neck metastasis
We then investigated correlations between pathological factors and delayed neck metastasis in the 65 patients with T1N0 tongue cancer (Table 2) . Muscle invasion was present in 36 (55.4%) patients and absent in 29 (44.6%). Delayed neck metastasis occurred in 17 (47.2%) of the 36 patients with muscle invasion and in 3 (10.3%) of the 29 patients without muscle invasion; this indicated that patients with muscle invasion were significantly more likely to develop delayed neck metastasis (P = 0.003). In terms of correlation with tumor thickness, the rate of occult neck metastasis was as follows: 1/18 (5.6%) for tumors <2 mm as compared with 19/47 (40.4%) for tumors ≥2 mm (P = 0.015); 4/28 (14.3%) for tumors <3 mm as compared with 16/37 (43.2%) for tumors ≥3 mm (P = 0.025) and 8/43 (18.6%) for tumors <4 mm as compared with 12/ 22 (54.5%) for tumors ≥4 mm (P = 0.007). Occult neck metastasis was significantly more frequent when tumor thickness was ≥2 mm. In terms of correlation with tumor depth, the rate of occult neck metastasis was as follows: 2/23 (8.7%) for tumors <2 mm as compared with 18/42 (42.9%) for tumors ≥2 mm (P = 0.010); 5/37 (13.5%) for tumors <3 mm as compared with 15/28 (53.6%) for tumors ≥3 mm (P = 0.001); and 8/43 (18.6%) for tumors <4 mm as compared with 12/22 (54.5%) for tumors ≥4 mm (P = 0.007). Thus, occult neck metastasis was also significantly more frequent for a tumor depth of ≥2 mm.
Pathological factors and survival rates
Next, to ascertain associations between pathological factors and prognosis, we investigated the relationship between DSS and muscle invasion, tumor thickness <2 mm or ≥2 mm and tumor depth <2 mm or ≥2 mm. Patients with muscle invasion displayed a significantly worse prognosis (P = 0.036), with a 5-year DSS of 96.6% for patients with no muscle invasion and 79.2% for those with muscle invasion (Fig. 4a) . Prognosis was also significantly worse for patients with a tumor thickness of ≥2 mm (P = 0.043); the 5-year DSS was 100% for patients with a tumor thickness of <2 mm and 81.9% for those with a tumor thickness of ≥2 mm (Fig. 4b) . Prognosis tended to be worse for patients with a tumor depth of ≥2 mm (P = 0.098); the 5-year DSS was 95.7% for patients with a tumor depth of <2 mm and 83.95% for those with a tumor depth of ≥2 mm (Fig. 4c ), but this difference was not statistically significant.
Tumor thickness on MR images and in pathological specimens
In the clinical setting, we are faced with the decision as to whether END should be performed or not before the acquirement of information from the surgical specimen from the primary lesion. MRI is one of the preferable modalities for the assessment of tumor thickness. Therefore, we examined the correlation between tumor thickness measured from MR images and surgical specimens. The mean and standard deviation values of tumor thickness from surgical specimens and MR images were 3.24 ± 2.12 mm and 3.97 ± 3.54 mm, respectively. The Pearson correlation between the tumor thickness measured on MR images and in surgical specimens was 0.85 ( Fig. 2b) , which was statistically significant (P < 0.001). Tumor thickness on MR images was well correlated with that in surgical specimens. Next, we assumed that thin tumors with a low risk of delayed neck metastasis would be difficult to detect using MRI. Undetectable tumors on MR images would be excluded as candidates for END at least. Thus, we examined whether or not tumors with a thickness of <2 mm or tumors with a thickness of ≥2 mm in surgical specimens were detectable using MRI. Fourteen cases had a tumor thickness of <2 mm. Two of them were detectable on MR images (14.3%) while the remainder were not. Thirty-one cases had tumors of thickness ≥2 mm and twenty-seven were detectable using MRI (87.1%); four cases were not. The tumors with a thickness of <2 mm in surgical specimens were unlikely to be detected using MRI in contrast to tumors with a thickness of ≥2 mm (P < 0.001).
Of the 45 cases where preoperative MR images were examined, 9 cases relapsed with delayed neck metastasis. The minimum tumor thickness detectable using MRI was 2.2 mm. Therefore, the percentage of patients with delayed neck metastasis was examined between the groups with a tumor thickness of ≥2 mm on MR images as detectable cases, and with a tumor thickness of <2 mm as undetectable cases. One out of 16 cases (6.3%) with a tumor thickness of <2 mm on MR images relapsed, whereas 8 cases out of 29 cases (27.6%) with a tumor thickness of ≥2 mm had recurrences. As to the tumors detectable using MRI, for those with a thickness ≥2 mm delayed neck metastasis tended to occur (P = 0.07); but the increase in incidence was not statistically significant.
Discussion
Until 2015, we treated all patients with T1N0 tongue cancer who did not initially exhibit cervical lymph-node metastasis using transoral primary resection followed by WW alone, without performing END. Our therapeutic results were comparatively favorable, with a 3-year OS of 85.7%, a 5-year OS of 79.4%, a 3-year DSS of 89.2% and a 5-year DSS of 87.3%. However, 9/67 patients died of the primary cancer; these 9 patients developed delayed neck recurrence in the early period after first surgery, implying that occult neck metastasis had been present. Nine of the twenty patients with occult metastasis died of the primary cancer; thus, control of occult neck metastasis in patients with T1N0 tongue cancer is a crucial issue. In decision analysis regarding neck management for patients with N0 head and neck cancer, elective neck treatment is recommended if the rate of occult metastasis is ≥20% (15) . With pathologies such as laryngeal and hypopharyngeal cancer, the neck is also part of the surgical field during the removal of the primary lesion. However, early-stage oral cancer, as addressed in this study, is removed transorally and the neck is not part of the surgical field during removal of the primary lesion. This would naturally lead to different outlooks concerning neck management between laryngeal and hypopharyngeal cancer on the one hand and early-stage oral cancer on the other. Assuming a 30% incidence of occult cervical lymph-node metastasis in T1N0 tongue cancer, overtreatment would put the 70% of patients without cervical lymph-node metastases at severe risk of the complications; these include new neck scars, neck stiffness, constriction, diminished shoulder function and marginal mandibular nerve injury. This represents a substantial argument against unnecessary neck dissection, with its attendant complications and risks, and in favor of WW. A prospective randomized comparative clinical trial has previously found no significant difference in prognosis between WW and END (7), and a retrospective study of 359 patients with T1N0 or T2N0 tongue cancer that compared prognosis between END and WW also found no significant difference between the groups (16) .
Another recent large-scale single center Phase III randomized comparative clinical trial involving a total of 500 participants, carried out at the same center as the one that conducted the retrospective study of 359 patients (16) , found that survival was significantly better for patients who underwent END as compared with WW (5). This represents strong evidence in support of END for early-stage oral cancer. In our study, patients with occult neck metastasis relapsed as delayed neck metastasis at an unfavorable pathological stage that was worse than rN2b or/and ECS positive. We also found that 45% of patients with occult neck metastasis died of the primary cancer, representing a poor prognosis. Although the proportion of patients with occult cervical lymph-node metastasis in our study (29.9%) was broadly similar to those reported by other authors (1-3) , delayed neck metastasis was present in patients as follows: 45.9% with muscle invasion, 40.4% with a tumor thickness of ≥2 mm, 43.2% with a tumor thickness of ≥3 mm and 54.5% with a tumor thickness of ≥4 mm. This indicated that a high proportion of patients with tumors that had entered the muscle layer or had a thickness as little as 2 mm had developed neck metastasis. The DSS rate was also significantly lower for patients with muscle invasion or a tumor thickness of ≥2 mm as compared with those without muscle invasion or with a tumor thickness of <2 mm. Therefore, patients diagnosed with Stage I tongue cancer who exhibit muscle invasion or thick tumors may include some individuals who are actually N1 or N2b stage III or IV. Our results suggested that patients with muscle invasion or a tumor thickness of ≥2 mm would benefit from END.
In the debate concerning tumor thickness, tumor depth and occult neck metastasis, the Phase III trial described above found that the rate of occult neck metastasis was 5.6% for a tumor depth of 3 mm and 16.9% for a tumor depth of 4 mm, representing a marked increase at this cutoff point (5) . A meta-analysis also found a metastasis rate of 4.5% for a tumor thickness of 4 mm, rising rapidly to 16.6% for a tumor thickness of 5 mm, suggesting that 4 mm may be the optimum cutoff value (17) . The National Comprehensive Cancer Network (NCCN) guidelines strongly recommend consideration of END for patients with a tumor thickness of ≥4 mm, while careful clinical judgment should be employed for tumors 2-to 4-mm thick when determining whether END is warranted (18) . Our patients exhibited higher rates of delayed neck metastases than has been reported in other studies, even at a tumor thickness of 2 mm. Results for patients who underwent END and were found to be positive for pathological neck metastasis were affected by the way in which pathological resection was carried out; thus, absolute proof that cases that were pathologically classified as N(−) actually represented N(−) is lacking. We consider that the results of the present study, in which the rate of occult neck metastasis was regarded as the proportion of patients who developed delayed neck metastasis after all patients had undergone WW, reflect the actual rate of occult neck metastasis.
Pathological tumor thickness and tumor depth are only apparent after surgery. However, the surgeon must make a preoperative decision on whether to undertake END. Results from our MRI study demonstrated that tumor thickness measured on MR images was well correlated with tumor thickness measured in surgical specimens. In contrast to tumors with a thickness of <2 mm, tumors with a thickness of ≥2 mm were significantly well detected using MRI. Therefore, MRI would be helpful in predicting tumor thickness as reported previously (19) , and would be helpful in deciding whether END is required. Another report focused on the utility of US of the tongue for predicting tumor thickness (20, 21) . Measurements of thickness made using US in the tongue exhibit a high degree of correlation (20) , and it may be another potential modality for deciding on the candidates for END.
In conclusion, although this was a retrospective study with a limited number of cases, it demonstrated that T1N0 tongue cancer patients with muscle invasion or tumors ≥2 mm thick developed delayed neck metastasis with unfavorable prognosis. These findings suggest that END may be warranted for patients with the abovementioned condition. Furthermore, MRI was a preferable modality for assessing preoperative tumor thickness; hence, it was auxiliary in surgical decision making.
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